©The Author(s) 2023.
World J Clin Cases. Jun 16, 2023; 11(17): 3993-4002
Published online Jun 16, 2023. doi: 10.12998/wjcc.v11.i17.3993
Published online Jun 16, 2023. doi: 10.12998/wjcc.v11.i17.3993
Table 2 Pearson correlation of elabela vs all study participants’ cases (n = 90)
| Variable | Pearson correlation | P value |
| BMI (kg/m2) | -0.090 | 0.4200 |
| Gestational age (wk) | 0.440 | < 0.0001 |
| Systolic BP (mmHg) | -0.800 | < 0.0001 |
| Diastolic BP (mmHg) | -0.640 | < 0.0001 |
| Mean arterial BP | -0.700 | < 0.0001 |
| AST (IU/L) | -0.110 | 0.2000 |
| ALT (IU/L) | 0.200 | < 0.0030 |
| Urea (mg/dL) | 0.004 | 0.9700 |
| Creatinine (mg/dL) | -0.310 | < 0.0030 |
| Albumin in urine | 0.160 | 0.2000 |
| Hemoglobin (g/dL) | 0.290 | < 0.0040 |
| Platelets count (× 109/L) | 0.480 | < 0.0001 |
- Citation: Amer Ali E, Nori W, Salman AF, Al-Rawi TSS, Hameed BH, Al-Ani RM. Elabela is a reliable biomarker for predicting early onset preeclampsia: A comparative study. World J Clin Cases 2023; 11(17): 3993-4002
- URL: https://www.wjgnet.com/2307-8960/full/v11/i17/3993.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i17.3993